nodes	percent_of_prediction	percent_of_DWPC	metapath
Flavoxate—PDE8B—leg—multiple sclerosis	0.0935	0.211	CbGeAlD
Flavoxate—PDE4C—brainstem—multiple sclerosis	0.0202	0.0456	CbGeAlD
Flavoxate—PDE7A—nervous system—multiple sclerosis	0.0164	0.0371	CbGeAlD
Flavoxate—PDE7A—central nervous system—multiple sclerosis	0.0158	0.0357	CbGeAlD
Flavoxate—PDE7B—nervous system—multiple sclerosis	0.0143	0.0324	CbGeAlD
Flavoxate—PDE8B—midbrain—multiple sclerosis	0.0139	0.0314	CbGeAlD
Flavoxate—PDE7B—central nervous system—multiple sclerosis	0.0138	0.0312	CbGeAlD
Flavoxate—PDE8A—medulla oblongata—multiple sclerosis	0.0137	0.0309	CbGeAlD
Flavoxate—PDE4C—midbrain—multiple sclerosis	0.0129	0.0291	CbGeAlD
Flavoxate—PDE7A—brain—multiple sclerosis	0.0125	0.0283	CbGeAlD
Flavoxate—PDE8A—midbrain—multiple sclerosis	0.0125	0.0282	CbGeAlD
Flavoxate—PDE8A—spinal cord—multiple sclerosis	0.0122	0.0275	CbGeAlD
Flavoxate—PDE8B—nervous system—multiple sclerosis	0.0114	0.0258	CbGeAlD
Flavoxate—PDE8B—central nervous system—multiple sclerosis	0.011	0.0248	CbGeAlD
Flavoxate—PDE7B—brain—multiple sclerosis	0.011	0.0248	CbGeAlD
Flavoxate—PDE8B—cerebellum—multiple sclerosis	0.0107	0.0243	CbGeAlD
Flavoxate—PDE4C—nervous system—multiple sclerosis	0.0106	0.0239	CbGeAlD
Flavoxate—PDE4C—central nervous system—multiple sclerosis	0.0102	0.023	CbGeAlD
Flavoxate—PDE8A—cerebellum—multiple sclerosis	0.00966	0.0218	CbGeAlD
Flavoxate—PDE4D—cerebellum—multiple sclerosis	0.00876	0.0198	CbGeAlD
Flavoxate—PDE8B—brain—multiple sclerosis	0.00873	0.0197	CbGeAlD
Flavoxate—PDE4C—brain—multiple sclerosis	0.00808	0.0183	CbGeAlD
Flavoxate—PDE8A—brain—multiple sclerosis	0.00785	0.0177	CbGeAlD
Flavoxate—PDE4A—cerebellum—multiple sclerosis	0.00775	0.0175	CbGeAlD
Flavoxate—PDE4D—brain—multiple sclerosis	0.00711	0.0161	CbGeAlD
Flavoxate—PDE4B—medulla oblongata—multiple sclerosis	0.00653	0.0148	CbGeAlD
Flavoxate—PDE4A—brain—multiple sclerosis	0.00629	0.0142	CbGeAlD
Flavoxate—PDE4B—midbrain—multiple sclerosis	0.00597	0.0135	CbGeAlD
Flavoxate—PDE4B—spinal cord—multiple sclerosis	0.00583	0.0132	CbGeAlD
Flavoxate—PDE4B—nervous system—multiple sclerosis	0.00491	0.0111	CbGeAlD
Flavoxate—CHRM2—nervous system—multiple sclerosis	0.00488	0.011	CbGeAlD
Flavoxate—PDE4B—central nervous system—multiple sclerosis	0.00473	0.0107	CbGeAlD
Flavoxate—CHRM2—central nervous system—multiple sclerosis	0.00469	0.0106	CbGeAlD
Flavoxate—PDE4B—cerebellum—multiple sclerosis	0.00462	0.0104	CbGeAlD
Flavoxate—CHRM1—nervous system—multiple sclerosis	0.00444	0.01	CbGeAlD
Flavoxate—CHRM1—central nervous system—multiple sclerosis	0.00427	0.00966	CbGeAlD
Flavoxate—PDE4B—brain—multiple sclerosis	0.00375	0.00848	CbGeAlD
Flavoxate—CHRM2—brain—multiple sclerosis	0.00373	0.00842	CbGeAlD
Flavoxate—CHRM1—brain—multiple sclerosis	0.00339	0.00767	CbGeAlD
Flavoxate—Vision blurred—Fingolimod—multiple sclerosis	0.00219	0.0396	CcSEcCtD
Flavoxate—Leukopenia—Fingolimod—multiple sclerosis	0.00208	0.0376	CcSEcCtD
Flavoxate—Palpitations—Fingolimod—multiple sclerosis	0.00205	0.0371	CcSEcCtD
Flavoxate—Eosinophilia—Cladribine—multiple sclerosis	0.00187	0.0338	CcSEcCtD
Flavoxate—Skin disorder—Fingolimod—multiple sclerosis	0.00184	0.0333	CcSEcCtD
Flavoxate—Headache—Fingolimod—multiple sclerosis	0.00119	0.0215	CcSEcCtD
Flavoxate—Drowsiness—Mitoxantrone—multiple sclerosis	0.00111	0.02	CcSEcCtD
Flavoxate—Confusional state—Cladribine—multiple sclerosis	0.00108	0.0196	CcSEcCtD
Flavoxate—Tachycardia—Cladribine—multiple sclerosis	0.00105	0.019	CcSEcCtD
Flavoxate—Skin disorder—Cladribine—multiple sclerosis	0.00104	0.0189	CcSEcCtD
Flavoxate—Leukopenia—Azathioprine—multiple sclerosis	0.000959	0.0173	CcSEcCtD
Flavoxate—Somnolence—Cladribine—multiple sclerosis	0.000956	0.0173	CcSEcCtD
Flavoxate—Feeling abnormal—Cladribine—multiple sclerosis	0.000886	0.016	CcSEcCtD
Flavoxate—Urticaria—Cladribine—multiple sclerosis	0.000854	0.0154	CcSEcCtD
Flavoxate—Skin disorder—Azathioprine—multiple sclerosis	0.000849	0.0153	CcSEcCtD
Flavoxate—Vision blurred—Mitoxantrone—multiple sclerosis	0.000816	0.0147	CcSEcCtD
Flavoxate—Leukopenia—Mitoxantrone—multiple sclerosis	0.000775	0.014	CcSEcCtD
Flavoxate—Feeling abnormal—Azathioprine—multiple sclerosis	0.00072	0.013	CcSEcCtD
Flavoxate—Confusional state—Mitoxantrone—multiple sclerosis	0.000713	0.0129	CcSEcCtD
Flavoxate—Tachycardia—Mitoxantrone—multiple sclerosis	0.00069	0.0125	CcSEcCtD
Flavoxate—Skin disorder—Mitoxantrone—multiple sclerosis	0.000686	0.0124	CcSEcCtD
Flavoxate—Vomiting—Cladribine—multiple sclerosis	0.000684	0.0124	CcSEcCtD
Flavoxate—Headache—Cladribine—multiple sclerosis	0.000673	0.0122	CcSEcCtD
Flavoxate—Vision blurred—Prednisolone—multiple sclerosis	0.000669	0.0121	CcSEcCtD
Flavoxate—Nausea—Cladribine—multiple sclerosis	0.000639	0.0115	CcSEcCtD
Flavoxate—Vertigo—Prednisolone—multiple sclerosis	0.000638	0.0115	CcSEcCtD
Flavoxate—Somnolence—Mitoxantrone—multiple sclerosis	0.000628	0.0114	CcSEcCtD
Flavoxate—Eosinophilia—Methotrexate—multiple sclerosis	0.000613	0.0111	CcSEcCtD
Flavoxate—Vertigo—Triamcinolone—multiple sclerosis	0.000587	0.0106	CcSEcCtD
Flavoxate—Vertigo—Methylprednisolone—multiple sclerosis	0.000586	0.0106	CcSEcCtD
Flavoxate—Feeling abnormal—Mitoxantrone—multiple sclerosis	0.000582	0.0105	CcSEcCtD
Flavoxate—Tachycardia—Prednisolone—multiple sclerosis	0.000566	0.0102	CcSEcCtD
Flavoxate—Urticaria—Mitoxantrone—multiple sclerosis	0.000561	0.0101	CcSEcCtD
Flavoxate—Vomiting—Azathioprine—multiple sclerosis	0.000556	0.01	CcSEcCtD
Flavoxate—Drowsiness—Methotrexate—multiple sclerosis	0.000552	0.00998	CcSEcCtD
Flavoxate—Headache—Azathioprine—multiple sclerosis	0.000548	0.0099	CcSEcCtD
Flavoxate—Dry mouth—Triamcinolone—multiple sclerosis	0.000544	0.00983	CcSEcCtD
Flavoxate—Confusional state—Methylprednisolone—multiple sclerosis	0.000536	0.00969	CcSEcCtD
Flavoxate—Vertigo—Betamethasone—multiple sclerosis	0.000533	0.00962	CcSEcCtD
Flavoxate—Vertigo—Dexamethasone—multiple sclerosis	0.000533	0.00962	CcSEcCtD
Flavoxate—Tachycardia—Triamcinolone—multiple sclerosis	0.00052	0.0094	CcSEcCtD
Flavoxate—Nausea—Azathioprine—multiple sclerosis	0.000519	0.00938	CcSEcCtD
Flavoxate—Tachycardia—Methylprednisolone—multiple sclerosis	0.000519	0.00938	CcSEcCtD
Flavoxate—Skin disorder—Methylprednisolone—multiple sclerosis	0.000517	0.00934	CcSEcCtD
Flavoxate—Vision blurred—Prednisone—multiple sclerosis	0.000486	0.00879	CcSEcCtD
Flavoxate—Feeling abnormal—Prednisolone—multiple sclerosis	0.000478	0.00863	CcSEcCtD
Flavoxate—Tachycardia—Betamethasone—multiple sclerosis	0.000472	0.00853	CcSEcCtD
Flavoxate—Tachycardia—Dexamethasone—multiple sclerosis	0.000472	0.00853	CcSEcCtD
Flavoxate—Vertigo—Prednisone—multiple sclerosis	0.000464	0.00838	CcSEcCtD
Flavoxate—Urticaria—Prednisolone—multiple sclerosis	0.000461	0.00832	CcSEcCtD
Flavoxate—Vomiting—Mitoxantrone—multiple sclerosis	0.000449	0.00812	CcSEcCtD
Flavoxate—Headache—Mitoxantrone—multiple sclerosis	0.000443	0.008	CcSEcCtD
Flavoxate—Feeling abnormal—Triamcinolone—multiple sclerosis	0.000439	0.00794	CcSEcCtD
Flavoxate—Feeling abnormal—Methylprednisolone—multiple sclerosis	0.000438	0.00792	CcSEcCtD
Flavoxate—Urticaria—Triamcinolone—multiple sclerosis	0.000424	0.00765	CcSEcCtD
Flavoxate—Urticaria—Methylprednisolone—multiple sclerosis	0.000423	0.00764	CcSEcCtD
Flavoxate—Nausea—Mitoxantrone—multiple sclerosis	0.00042	0.00759	CcSEcCtD
Flavoxate—Tachycardia—Prednisone—multiple sclerosis	0.000411	0.00743	CcSEcCtD
Flavoxate—Skin disorder—Prednisone—multiple sclerosis	0.000409	0.0074	CcSEcCtD
Flavoxate—Vision blurred—Methotrexate—multiple sclerosis	0.000407	0.00735	CcSEcCtD
Flavoxate—Feeling abnormal—Betamethasone—multiple sclerosis	0.000399	0.0072	CcSEcCtD
Flavoxate—Feeling abnormal—Dexamethasone—multiple sclerosis	0.000399	0.0072	CcSEcCtD
Flavoxate—Vertigo—Methotrexate—multiple sclerosis	0.000388	0.007	CcSEcCtD
Flavoxate—Leukopenia—Methotrexate—multiple sclerosis	0.000386	0.00698	CcSEcCtD
Flavoxate—Urticaria—Betamethasone—multiple sclerosis	0.000384	0.00695	CcSEcCtD
Flavoxate—Urticaria—Dexamethasone—multiple sclerosis	0.000384	0.00695	CcSEcCtD
Flavoxate—Headache—Prednisolone—multiple sclerosis	0.000363	0.00656	CcSEcCtD
Flavoxate—Confusional state—Methotrexate—multiple sclerosis	0.000355	0.00642	CcSEcCtD
Flavoxate—Feeling abnormal—Prednisone—multiple sclerosis	0.000347	0.00627	CcSEcCtD
Flavoxate—Nausea—Prednisolone—multiple sclerosis	0.000344	0.00622	CcSEcCtD
Flavoxate—Skin disorder—Methotrexate—multiple sclerosis	0.000342	0.00618	CcSEcCtD
Flavoxate—Vomiting—Triamcinolone—multiple sclerosis	0.000339	0.00613	CcSEcCtD
Flavoxate—Vomiting—Methylprednisolone—multiple sclerosis	0.000338	0.00611	CcSEcCtD
Flavoxate—Urticaria—Prednisone—multiple sclerosis	0.000335	0.00605	CcSEcCtD
Flavoxate—Headache—Triamcinolone—multiple sclerosis	0.000334	0.00604	CcSEcCtD
Flavoxate—Headache—Methylprednisolone—multiple sclerosis	0.000333	0.00602	CcSEcCtD
Flavoxate—Nausea—Triamcinolone—multiple sclerosis	0.000317	0.00572	CcSEcCtD
Flavoxate—Nausea—Methylprednisolone—multiple sclerosis	0.000316	0.00571	CcSEcCtD
Flavoxate—Somnolence—Methotrexate—multiple sclerosis	0.000313	0.00566	CcSEcCtD
Flavoxate—Vomiting—Dexamethasone—multiple sclerosis	0.000308	0.00556	CcSEcCtD
Flavoxate—Vomiting—Betamethasone—multiple sclerosis	0.000308	0.00556	CcSEcCtD
Flavoxate—Headache—Dexamethasone—multiple sclerosis	0.000303	0.00548	CcSEcCtD
Flavoxate—Headache—Betamethasone—multiple sclerosis	0.000303	0.00548	CcSEcCtD
Flavoxate—Feeling abnormal—Methotrexate—multiple sclerosis	0.00029	0.00524	CcSEcCtD
Flavoxate—Nausea—Dexamethasone—multiple sclerosis	0.000287	0.00519	CcSEcCtD
Flavoxate—Nausea—Betamethasone—multiple sclerosis	0.000287	0.00519	CcSEcCtD
Flavoxate—Urticaria—Methotrexate—multiple sclerosis	0.00028	0.00505	CcSEcCtD
Flavoxate—Vomiting—Prednisone—multiple sclerosis	0.000268	0.00484	CcSEcCtD
Flavoxate—Headache—Prednisone—multiple sclerosis	0.000264	0.00477	CcSEcCtD
Flavoxate—Nausea—Prednisone—multiple sclerosis	0.00025	0.00452	CcSEcCtD
Flavoxate—PDE4B—Signaling Pathways—CNR1—multiple sclerosis	0.000235	0.000467	CbGpPWpGaD
Flavoxate—PDE4A—Signaling by GPCR—POMC—multiple sclerosis	0.000234	0.000466	CbGpPWpGaD
Flavoxate—CHRM1—Class A/1 (Rhodopsin-like receptors)—CCL2—multiple sclerosis	0.000233	0.000464	CbGpPWpGaD
Flavoxate—CHRM1—GPCR ligand binding—CCR5—multiple sclerosis	0.000232	0.000462	CbGpPWpGaD
Flavoxate—PDE4C—GPCR downstream signaling—IL2—multiple sclerosis	0.00023	0.000458	CbGpPWpGaD
Flavoxate—CHRM2—Class A/1 (Rhodopsin-like receptors)—CCL2—multiple sclerosis	0.00023	0.000458	CbGpPWpGaD
Flavoxate—CHRM1—Signaling Pathways—S1PR1—multiple sclerosis	0.00023	0.000458	CbGpPWpGaD
Flavoxate—PDE4A—Signaling by GPCR—CCL2—multiple sclerosis	0.000229	0.000456	CbGpPWpGaD
Flavoxate—CHRM2—GPCR ligand binding—CCR5—multiple sclerosis	0.000229	0.000456	CbGpPWpGaD
Flavoxate—PDE8A—Signaling Pathways—IL2—multiple sclerosis	0.000229	0.000455	CbGpPWpGaD
Flavoxate—PDE8B—Signaling Pathways—IL2—multiple sclerosis	0.000229	0.000455	CbGpPWpGaD
Flavoxate—PDE4A—Signaling Pathways—CXCL10—multiple sclerosis	0.000228	0.000455	CbGpPWpGaD
Flavoxate—PDE7A—Signaling Pathways—TYK2—multiple sclerosis	0.000228	0.000453	CbGpPWpGaD
Flavoxate—PDE8A—Signaling by GPCR—IL6—multiple sclerosis	0.000227	0.000453	CbGpPWpGaD
Flavoxate—PDE8B—Signaling by GPCR—IL6—multiple sclerosis	0.000227	0.000453	CbGpPWpGaD
Flavoxate—CHRM2—Signaling Pathways—S1PR1—multiple sclerosis	0.000227	0.000452	CbGpPWpGaD
Flavoxate—Vomiting—Methotrexate—multiple sclerosis	0.000224	0.00405	CcSEcCtD
Flavoxate—CHRM1—Signaling Pathways—GPC5—multiple sclerosis	0.000224	0.000445	CbGpPWpGaD
Flavoxate—CHRM2—SIDS Susceptibility Pathways—TNF—multiple sclerosis	0.000221	0.00044	CbGpPWpGaD
Flavoxate—CHRM2—Signaling Pathways—GPC5—multiple sclerosis	0.000221	0.000439	CbGpPWpGaD
Flavoxate—Headache—Methotrexate—multiple sclerosis	0.000221	0.00399	CcSEcCtD
Flavoxate—PDE4C—Signaling Pathways—SPP1—multiple sclerosis	0.00022	0.000437	CbGpPWpGaD
Flavoxate—PDE4D—Signaling by GPCR—TYK2—multiple sclerosis	0.000219	0.000435	CbGpPWpGaD
Flavoxate—PDE4B—Signaling by GPCR—POMC—multiple sclerosis	0.000217	0.000431	CbGpPWpGaD
Flavoxate—CHRM1—GPCR downstream signaling—PTGER4—multiple sclerosis	0.000217	0.000431	CbGpPWpGaD
Flavoxate—PDE8B—Signaling Pathways—MMP9—multiple sclerosis	0.000216	0.000431	CbGpPWpGaD
Flavoxate—PDE8A—Signaling Pathways—MMP9—multiple sclerosis	0.000216	0.000431	CbGpPWpGaD
Flavoxate—CHRM2—GPCR downstream signaling—PTGER4—multiple sclerosis	0.000214	0.000426	CbGpPWpGaD
Flavoxate—PDE4C—Signaling Pathways—CCR5—multiple sclerosis	0.000214	0.000425	CbGpPWpGaD
Flavoxate—PDE4B—Signaling by GPCR—CCL2—multiple sclerosis	0.000212	0.000422	CbGpPWpGaD
Flavoxate—PDE4B—Signaling Pathways—CXCL10—multiple sclerosis	0.000211	0.000421	CbGpPWpGaD
Flavoxate—PDE4C—Signaling Pathways—IL2RA—multiple sclerosis	0.000211	0.000419	CbGpPWpGaD
Flavoxate—PDE4D—Signaling Pathways—CD86—multiple sclerosis	0.00021	0.000418	CbGpPWpGaD
Flavoxate—CHRM1—GPCR downstream signaling—CXCR3—multiple sclerosis	0.000209	0.000417	CbGpPWpGaD
Flavoxate—Nausea—Methotrexate—multiple sclerosis	0.000209	0.00378	CcSEcCtD
Flavoxate—PDE4C—Signaling by GPCR—IL2—multiple sclerosis	0.000209	0.000416	CbGpPWpGaD
Flavoxate—PDE4A—Signaling by GPCR—TYK2—multiple sclerosis	0.000208	0.000414	CbGpPWpGaD
Flavoxate—CHRM2—GPCR downstream signaling—CXCR3—multiple sclerosis	0.000207	0.000411	CbGpPWpGaD
Flavoxate—PDE4D—Signaling Pathways—CCL5—multiple sclerosis	0.000206	0.000411	CbGpPWpGaD
Flavoxate—CHRM1—Signaling by GPCR—CCL3—multiple sclerosis	0.000204	0.000407	CbGpPWpGaD
Flavoxate—PDE7B—Signaling Pathways—IL2—multiple sclerosis	0.000204	0.000406	CbGpPWpGaD
Flavoxate—CHRM1—GPCR downstream signaling—CCR2—multiple sclerosis	0.000204	0.000405	CbGpPWpGaD
Flavoxate—PDE7B—Signaling by GPCR—IL6—multiple sclerosis	0.000203	0.000404	CbGpPWpGaD
Flavoxate—CHRM2—Signaling by GPCR—CCL3—multiple sclerosis	0.000202	0.000402	CbGpPWpGaD
Flavoxate—CHRM2—GPCR downstream signaling—CCR2—multiple sclerosis	0.000201	0.0004	CbGpPWpGaD
Flavoxate—PDE4D—GPCR downstream signaling—IL2—multiple sclerosis	0.0002	0.000399	CbGpPWpGaD
Flavoxate—PDE4A—Signaling Pathways—CD86—multiple sclerosis	0.0002	0.000397	CbGpPWpGaD
Flavoxate—CHRM1—Signaling by GPCR—PTGER4—multiple sclerosis	0.000197	0.000392	CbGpPWpGaD
Flavoxate—PDE4A—Signaling Pathways—CCL5—multiple sclerosis	0.000197	0.000391	CbGpPWpGaD
Flavoxate—CHRM1—Signaling Pathways—RGS1—multiple sclerosis	0.000195	0.000389	CbGpPWpGaD
Flavoxate—PDE4C—Signaling Pathways—APOE—multiple sclerosis	0.000194	0.000387	CbGpPWpGaD
Flavoxate—CHRM2—Signaling by GPCR—PTGER4—multiple sclerosis	0.000194	0.000387	CbGpPWpGaD
Flavoxate—CHRM2—Signaling Pathways—RGS1—multiple sclerosis	0.000193	0.000384	CbGpPWpGaD
Flavoxate—PDE7B—Signaling Pathways—MMP9—multiple sclerosis	0.000193	0.000384	CbGpPWpGaD
Flavoxate—PDE4B—Signaling by GPCR—TYK2—multiple sclerosis	0.000193	0.000383	CbGpPWpGaD
Flavoxate—PDE8A—Signaling Pathways—STAT3—multiple sclerosis	0.000192	0.000383	CbGpPWpGaD
Flavoxate—PDE8B—Signaling Pathways—STAT3—multiple sclerosis	0.000192	0.000383	CbGpPWpGaD
Flavoxate—PDE4D—Signaling Pathways—SPP1—multiple sclerosis	0.000191	0.000381	CbGpPWpGaD
Flavoxate—PDE4A—GPCR downstream signaling—IL2—multiple sclerosis	0.000191	0.00038	CbGpPWpGaD
Flavoxate—CHRM1—Signaling by GPCR—CXCR3—multiple sclerosis	0.00019	0.000378	CbGpPWpGaD
Flavoxate—PDE7A—Signaling Pathways—IL2—multiple sclerosis	0.000189	0.000377	CbGpPWpGaD
Flavoxate—PDE7A—Signaling by GPCR—IL6—multiple sclerosis	0.000188	0.000375	CbGpPWpGaD
Flavoxate—CHRM1—GPCR downstream signaling—CNR1—multiple sclerosis	0.000188	0.000374	CbGpPWpGaD
Flavoxate—CHRM2—Signaling by GPCR—CXCR3—multiple sclerosis	0.000188	0.000373	CbGpPWpGaD
Flavoxate—PDE4D—Signaling Pathways—CCR5—multiple sclerosis	0.000186	0.00037	CbGpPWpGaD
Flavoxate—CHRM2—GPCR downstream signaling—CNR1—multiple sclerosis	0.000185	0.000369	CbGpPWpGaD
Flavoxate—CHRM1—Signaling Pathways—GPR65—multiple sclerosis	0.000185	0.000369	CbGpPWpGaD
Flavoxate—CHRM1—Signaling by GPCR—CCR2—multiple sclerosis	0.000185	0.000368	CbGpPWpGaD
Flavoxate—PDE4B—Signaling Pathways—CD86—multiple sclerosis	0.000185	0.000368	CbGpPWpGaD
Flavoxate—PDE4D—Signaling Pathways—IL2RA—multiple sclerosis	0.000183	0.000365	CbGpPWpGaD
Flavoxate—CHRM2—Signaling Pathways—GPR65—multiple sclerosis	0.000183	0.000364	CbGpPWpGaD
Flavoxate—CHRM2—Signaling by GPCR—CCR2—multiple sclerosis	0.000182	0.000363	CbGpPWpGaD
Flavoxate—PDE4A—Signaling Pathways—SPP1—multiple sclerosis	0.000182	0.000362	CbGpPWpGaD
Flavoxate—PDE4D—Signaling by GPCR—IL2—multiple sclerosis	0.000182	0.000362	CbGpPWpGaD
Flavoxate—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—MAPK1—multiple sclerosis	0.000182	0.000362	CbGpPWpGaD
Flavoxate—PDE4B—Signaling Pathways—CCL5—multiple sclerosis	0.000182	0.000362	CbGpPWpGaD
Flavoxate—CHRM1—GPCR ligand binding—POMC—multiple sclerosis	0.000181	0.000361	CbGpPWpGaD
Flavoxate—PDE7A—Signaling Pathways—MMP9—multiple sclerosis	0.000179	0.000357	CbGpPWpGaD
Flavoxate—CHRM2—GPCR ligand binding—POMC—multiple sclerosis	0.000179	0.000356	CbGpPWpGaD
Flavoxate—PDE8B—Signaling Pathways—MYC—multiple sclerosis	0.000179	0.000356	CbGpPWpGaD
Flavoxate—PDE8A—Signaling Pathways—MYC—multiple sclerosis	0.000179	0.000356	CbGpPWpGaD
Flavoxate—CHRM2—SIDS Susceptibility Pathways—IL6—multiple sclerosis	0.000178	0.000355	CbGpPWpGaD
Flavoxate—PDE8B—Signaling Pathways—TGFB1—multiple sclerosis	0.000178	0.000355	CbGpPWpGaD
Flavoxate—PDE8A—Signaling Pathways—TGFB1—multiple sclerosis	0.000178	0.000355	CbGpPWpGaD
Flavoxate—CHRM1—GPCR ligand binding—CCL2—multiple sclerosis	0.000177	0.000353	CbGpPWpGaD
Flavoxate—PDE4A—Signaling Pathways—CCR5—multiple sclerosis	0.000177	0.000352	CbGpPWpGaD
Flavoxate—PDE4B—GPCR downstream signaling—IL2—multiple sclerosis	0.000176	0.000351	CbGpPWpGaD
Flavoxate—PDE4C—Signaling Pathways—CD80—multiple sclerosis	0.000176	0.00035	CbGpPWpGaD
Flavoxate—CHRM2—GPCR ligand binding—CCL2—multiple sclerosis	0.000175	0.000349	CbGpPWpGaD
Flavoxate—PDE8B—Signaling Pathways—MAPK1—multiple sclerosis	0.000175	0.000348	CbGpPWpGaD
Flavoxate—PDE8A—Signaling Pathways—MAPK1—multiple sclerosis	0.000175	0.000348	CbGpPWpGaD
Flavoxate—PDE4A—Signaling Pathways—IL2RA—multiple sclerosis	0.000174	0.000347	CbGpPWpGaD
Flavoxate—PDE4A—Signaling by GPCR—IL2—multiple sclerosis	0.000173	0.000345	CbGpPWpGaD
Flavoxate—PDE7B—Signaling Pathways—STAT3—multiple sclerosis	0.000171	0.000341	CbGpPWpGaD
Flavoxate—CHRM1—Signaling by GPCR—CNR1—multiple sclerosis	0.000171	0.00034	CbGpPWpGaD
Flavoxate—CHRM1—Signaling Pathways—CXCL13—multiple sclerosis	0.000169	0.000337	CbGpPWpGaD
Flavoxate—CHRM1—Signaling Pathways—CCR1—multiple sclerosis	0.000169	0.000337	CbGpPWpGaD
Flavoxate—PDE4D—Signaling Pathways—APOE—multiple sclerosis	0.000169	0.000337	CbGpPWpGaD
Flavoxate—CHRM1—GPCR downstream signaling—CXCL10—multiple sclerosis	0.000169	0.000337	CbGpPWpGaD
Flavoxate—PDE4B—Signaling Pathways—SPP1—multiple sclerosis	0.000168	0.000335	CbGpPWpGaD
Flavoxate—CHRM2—Signaling by GPCR—CNR1—multiple sclerosis	0.000168	0.000335	CbGpPWpGaD
Flavoxate—CHRM2—Signaling Pathways—CCR1—multiple sclerosis	0.000167	0.000333	CbGpPWpGaD
Flavoxate—CHRM2—Signaling Pathways—CXCL13—multiple sclerosis	0.000167	0.000333	CbGpPWpGaD
Flavoxate—PDE4C—Signaling Pathways—POMC—multiple sclerosis	0.000167	0.000332	CbGpPWpGaD
Flavoxate—CHRM2—GPCR downstream signaling—CXCL10—multiple sclerosis	0.000167	0.000332	CbGpPWpGaD
Flavoxate—PDE4B—Signaling Pathways—CCR5—multiple sclerosis	0.000164	0.000326	CbGpPWpGaD
Flavoxate—PDE4C—Signaling Pathways—CCL2—multiple sclerosis	0.000163	0.000325	CbGpPWpGaD
Flavoxate—PDE4B—Signaling Pathways—IL2RA—multiple sclerosis	0.000161	0.000321	CbGpPWpGaD
Flavoxate—PDE4A—Signaling Pathways—APOE—multiple sclerosis	0.000161	0.000321	CbGpPWpGaD
Flavoxate—PDE4B—Signaling by GPCR—IL2—multiple sclerosis	0.00016	0.000319	CbGpPWpGaD
Flavoxate—PDE4C—Signaling by GPCR—MAPK1—multiple sclerosis	0.00016	0.000318	CbGpPWpGaD
Flavoxate—PDE7A—Signaling Pathways—STAT3—multiple sclerosis	0.000159	0.000317	CbGpPWpGaD
Flavoxate—PDE7B—Signaling Pathways—MYC—multiple sclerosis	0.000159	0.000317	CbGpPWpGaD
Flavoxate—PDE7B—Signaling Pathways—TGFB1—multiple sclerosis	0.000159	0.000316	CbGpPWpGaD
Flavoxate—PDE7B—Signaling Pathways—MAPK1—multiple sclerosis	0.000156	0.00031	CbGpPWpGaD
Flavoxate—CHRM1—Signaling by GPCR—CXCL10—multiple sclerosis	0.000154	0.000306	CbGpPWpGaD
Flavoxate—PDE4D—Signaling Pathways—CD80—multiple sclerosis	0.000153	0.000305	CbGpPWpGaD
Flavoxate—CHRM2—Signaling by GPCR—CXCL10—multiple sclerosis	0.000152	0.000302	CbGpPWpGaD
Flavoxate—PDE4B—Signaling Pathways—APOE—multiple sclerosis	0.000149	0.000297	CbGpPWpGaD
Flavoxate—PDE4C—Signaling Pathways—TYK2—multiple sclerosis	0.000148	0.000295	CbGpPWpGaD
Flavoxate—PDE7A—Signaling Pathways—MYC—multiple sclerosis	0.000148	0.000295	CbGpPWpGaD
Flavoxate—PDE7A—Signaling Pathways—TGFB1—multiple sclerosis	0.000148	0.000294	CbGpPWpGaD
Flavoxate—CHRM1—Circadian rythm related genes—IL6—multiple sclerosis	0.000148	0.000294	CbGpPWpGaD
Flavoxate—PDE4A—Signaling Pathways—CD80—multiple sclerosis	0.000146	0.00029	CbGpPWpGaD
Flavoxate—CHRM1—GPCR downstream signaling—CCL5—multiple sclerosis	0.000146	0.00029	CbGpPWpGaD
Flavoxate—PDE4D—Signaling Pathways—POMC—multiple sclerosis	0.000145	0.000289	CbGpPWpGaD
Flavoxate—PDE7A—Signaling Pathways—MAPK1—multiple sclerosis	0.000145	0.000289	CbGpPWpGaD
Flavoxate—CHRM2—GPCR downstream signaling—CCL5—multiple sclerosis	0.000144	0.000286	CbGpPWpGaD
Flavoxate—PDE4D—Signaling Pathways—CCL2—multiple sclerosis	0.000142	0.000283	CbGpPWpGaD
Flavoxate—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—multiple sclerosis	0.00014	0.000278	CbGpPWpGaD
Flavoxate—PDE4D—Signaling by GPCR—MAPK1—multiple sclerosis	0.000139	0.000277	CbGpPWpGaD
Flavoxate—PDE4A—Signaling Pathways—POMC—multiple sclerosis	0.000138	0.000275	CbGpPWpGaD
Flavoxate—PDE4A—Signaling Pathways—CCL2—multiple sclerosis	0.000135	0.00027	CbGpPWpGaD
Flavoxate—PDE4B—Signaling Pathways—CD80—multiple sclerosis	0.000135	0.000268	CbGpPWpGaD
Flavoxate—PDE8A—Signaling Pathways—IL6—multiple sclerosis	0.000134	0.000268	CbGpPWpGaD
Flavoxate—PDE8B—Signaling Pathways—IL6—multiple sclerosis	0.000134	0.000268	CbGpPWpGaD
Flavoxate—PDE4A—Signaling by GPCR—MAPK1—multiple sclerosis	0.000132	0.000264	CbGpPWpGaD
Flavoxate—CHRM1—Signaling by GPCR—CCL5—multiple sclerosis	0.000132	0.000263	CbGpPWpGaD
Flavoxate—CHRM1—GPCR downstream signaling—CCR5—multiple sclerosis	0.000131	0.000261	CbGpPWpGaD
Flavoxate—CHRM2—Signaling by GPCR—CCL5—multiple sclerosis	0.00013	0.00026	CbGpPWpGaD
Flavoxate—CHRM2—GPCR downstream signaling—CCR5—multiple sclerosis	0.000129	0.000258	CbGpPWpGaD
Flavoxate—CHRM1—GPCR downstream signaling—IL2RA—multiple sclerosis	0.000129	0.000257	CbGpPWpGaD
Flavoxate—PDE4D—Signaling Pathways—TYK2—multiple sclerosis	0.000129	0.000257	CbGpPWpGaD
Flavoxate—PDE4B—Signaling Pathways—POMC—multiple sclerosis	0.000128	0.000255	CbGpPWpGaD
Flavoxate—CHRM2—GPCR downstream signaling—IL2RA—multiple sclerosis	0.000128	0.000254	CbGpPWpGaD
Flavoxate—PDE4B—Signaling Pathways—CCL2—multiple sclerosis	0.000125	0.000249	CbGpPWpGaD
Flavoxate—PDE4C—Signaling Pathways—IL2—multiple sclerosis	0.000123	0.000246	CbGpPWpGaD
Flavoxate—PDE4A—Signaling Pathways—TYK2—multiple sclerosis	0.000123	0.000245	CbGpPWpGaD
Flavoxate—PDE4C—Signaling by GPCR—IL6—multiple sclerosis	0.000123	0.000245	CbGpPWpGaD
Flavoxate—PDE4B—Signaling by GPCR—MAPK1—multiple sclerosis	0.000123	0.000244	CbGpPWpGaD
Flavoxate—CHRM1—Signaling Pathways—CCL3—multiple sclerosis	0.000121	0.00024	CbGpPWpGaD
Flavoxate—PDE7B—Signaling Pathways—IL6—multiple sclerosis	0.00012	0.000238	CbGpPWpGaD
Flavoxate—CHRM2—Signaling Pathways—CCL3—multiple sclerosis	0.000119	0.000237	CbGpPWpGaD
Flavoxate—CHRM1—Signaling by GPCR—CCR5—multiple sclerosis	0.000119	0.000237	CbGpPWpGaD
Flavoxate—CHRM2—Signaling by GPCR—CCR5—multiple sclerosis	0.000118	0.000234	CbGpPWpGaD
Flavoxate—CHRM1—Signaling by GPCR—IL2RA—multiple sclerosis	0.000117	0.000234	CbGpPWpGaD
Flavoxate—PDE4C—Signaling Pathways—MMP9—multiple sclerosis	0.000117	0.000233	CbGpPWpGaD
Flavoxate—CHRM1—Signaling Pathways—PTGER4—multiple sclerosis	0.000116	0.000231	CbGpPWpGaD
Flavoxate—CHRM2—Signaling by GPCR—IL2RA—multiple sclerosis	0.000116	0.000231	CbGpPWpGaD
Flavoxate—CHRM2—Signaling Pathways—PTGER4—multiple sclerosis	0.000115	0.000228	CbGpPWpGaD
Flavoxate—CHRM1—Signaling Pathways—PGR—multiple sclerosis	0.000114	0.000228	CbGpPWpGaD
Flavoxate—PDE4B—Signaling Pathways—TYK2—multiple sclerosis	0.000114	0.000226	CbGpPWpGaD
Flavoxate—CHRM2—Signaling Pathways—PGR—multiple sclerosis	0.000113	0.000225	CbGpPWpGaD
Flavoxate—CHRM1—Signaling Pathways—CXCR3—multiple sclerosis	0.000112	0.000223	CbGpPWpGaD
Flavoxate—PDE7A—Signaling Pathways—IL6—multiple sclerosis	0.000111	0.000222	CbGpPWpGaD
Flavoxate—CHRM1—Signaling Pathways—CD28—multiple sclerosis	0.000111	0.000221	CbGpPWpGaD
Flavoxate—CHRM2—Signaling Pathways—CXCR3—multiple sclerosis	0.000111	0.000221	CbGpPWpGaD
Flavoxate—CHRM2—Signaling Pathways—CD28—multiple sclerosis	0.00011	0.000219	CbGpPWpGaD
Flavoxate—CHRM1—Signaling Pathways—CCR2—multiple sclerosis	0.000109	0.000217	CbGpPWpGaD
Flavoxate—CHRM2—Signaling Pathways—CCR2—multiple sclerosis	0.000108	0.000215	CbGpPWpGaD
Flavoxate—PDE4D—Signaling Pathways—IL2—multiple sclerosis	0.000107	0.000214	CbGpPWpGaD
Flavoxate—PDE4D—Signaling by GPCR—IL6—multiple sclerosis	0.000107	0.000213	CbGpPWpGaD
Flavoxate—PDE4C—Signaling Pathways—STAT3—multiple sclerosis	0.000104	0.000207	CbGpPWpGaD
Flavoxate—CHRM1—GPCR downstream signaling—POMC—multiple sclerosis	0.000102	0.000204	CbGpPWpGaD
Flavoxate—PDE4A—Signaling Pathways—IL2—multiple sclerosis	0.000102	0.000204	CbGpPWpGaD
Flavoxate—PDE4A—Signaling by GPCR—IL6—multiple sclerosis	0.000102	0.000203	CbGpPWpGaD
Flavoxate—PDE4D—Signaling Pathways—MMP9—multiple sclerosis	0.000102	0.000203	CbGpPWpGaD
Flavoxate—CHRM2—GPCR downstream signaling—POMC—multiple sclerosis	0.000101	0.000201	CbGpPWpGaD
Flavoxate—CHRM1—Signaling Pathways—CNR1—multiple sclerosis	0.000101	0.000201	CbGpPWpGaD
Flavoxate—CHRM2—Signaling Pathways—CNR1—multiple sclerosis	9.95e-05	0.000198	CbGpPWpGaD
Flavoxate—PDE4A—Signaling Pathways—MMP9—multiple sclerosis	9.68e-05	0.000193	CbGpPWpGaD
Flavoxate—PDE4C—Signaling Pathways—MYC—multiple sclerosis	9.65e-05	0.000192	CbGpPWpGaD
Flavoxate—PDE4C—Signaling Pathways—TGFB1—multiple sclerosis	9.63e-05	0.000192	CbGpPWpGaD
Flavoxate—PDE4B—Signaling Pathways—IL2—multiple sclerosis	9.46e-05	0.000188	CbGpPWpGaD
Flavoxate—PDE4C—Signaling Pathways—MAPK1—multiple sclerosis	9.44e-05	0.000188	CbGpPWpGaD
Flavoxate—PDE4B—Signaling by GPCR—IL6—multiple sclerosis	9.42e-05	0.000188	CbGpPWpGaD
Flavoxate—CHRM1—Signaling by GPCR—POMC—multiple sclerosis	9.31e-05	0.000185	CbGpPWpGaD
Flavoxate—CHRM2—Signaling by GPCR—POMC—multiple sclerosis	9.19e-05	0.000183	CbGpPWpGaD
Flavoxate—CHRM1—Signaling by GPCR—CCL2—multiple sclerosis	9.11e-05	0.000181	CbGpPWpGaD
Flavoxate—CHRM1—Signaling Pathways—CXCL10—multiple sclerosis	9.07e-05	0.000181	CbGpPWpGaD
Flavoxate—PDE4D—Signaling Pathways—STAT3—multiple sclerosis	9.04e-05	0.00018	CbGpPWpGaD
Flavoxate—CHRM2—Signaling by GPCR—CCL2—multiple sclerosis	8.99e-05	0.000179	CbGpPWpGaD
Flavoxate—PDE4B—Signaling Pathways—MMP9—multiple sclerosis	8.96e-05	0.000178	CbGpPWpGaD
Flavoxate—CHRM2—Signaling Pathways—CXCL10—multiple sclerosis	8.96e-05	0.000178	CbGpPWpGaD
Flavoxate—PDE4A—Signaling Pathways—STAT3—multiple sclerosis	8.61e-05	0.000171	CbGpPWpGaD
Flavoxate—PDE4D—Signaling Pathways—MYC—multiple sclerosis	8.4e-05	0.000167	CbGpPWpGaD
Flavoxate—PDE4D—Signaling Pathways—TGFB1—multiple sclerosis	8.38e-05	0.000167	CbGpPWpGaD
Flavoxate—CHRM1—Signaling by GPCR—TYK2—multiple sclerosis	8.27e-05	0.000165	CbGpPWpGaD
Flavoxate—PDE4D—Signaling Pathways—MAPK1—multiple sclerosis	8.22e-05	0.000164	CbGpPWpGaD
Flavoxate—CHRM2—Signaling by GPCR—TYK2—multiple sclerosis	8.16e-05	0.000163	CbGpPWpGaD
Flavoxate—PDE4A—Signaling Pathways—MYC—multiple sclerosis	8e-05	0.000159	CbGpPWpGaD
Flavoxate—PDE4A—Signaling Pathways—TGFB1—multiple sclerosis	7.98e-05	0.000159	CbGpPWpGaD
Flavoxate—PDE4B—Signaling Pathways—STAT3—multiple sclerosis	7.96e-05	0.000159	CbGpPWpGaD
Flavoxate—CHRM1—Signaling Pathways—CD86—multiple sclerosis	7.93e-05	0.000158	CbGpPWpGaD
Flavoxate—CHRM2—Signaling Pathways—CD86—multiple sclerosis	7.83e-05	0.000156	CbGpPWpGaD
Flavoxate—PDE4A—Signaling Pathways—MAPK1—multiple sclerosis	7.82e-05	0.000156	CbGpPWpGaD
Flavoxate—CHRM1—Signaling Pathways—CCL5—multiple sclerosis	7.81e-05	0.000155	CbGpPWpGaD
Flavoxate—CHRM2—Signaling Pathways—CCL5—multiple sclerosis	7.71e-05	0.000153	CbGpPWpGaD
Flavoxate—CHRM1—GPCR downstream signaling—IL2—multiple sclerosis	7.58e-05	0.000151	CbGpPWpGaD
Flavoxate—CHRM2—GPCR downstream signaling—IL2—multiple sclerosis	7.48e-05	0.000149	CbGpPWpGaD
Flavoxate—PDE4B—Signaling Pathways—MYC—multiple sclerosis	7.4e-05	0.000147	CbGpPWpGaD
Flavoxate—PDE4B—Signaling Pathways—TGFB1—multiple sclerosis	7.38e-05	0.000147	CbGpPWpGaD
Flavoxate—PDE4C—Signaling Pathways—IL6—multiple sclerosis	7.26e-05	0.000144	CbGpPWpGaD
Flavoxate—PDE4B—Signaling Pathways—MAPK1—multiple sclerosis	7.24e-05	0.000144	CbGpPWpGaD
Flavoxate—CHRM1—Signaling Pathways—SPP1—multiple sclerosis	7.23e-05	0.000144	CbGpPWpGaD
Flavoxate—CHRM2—Signaling Pathways—SPP1—multiple sclerosis	7.14e-05	0.000142	CbGpPWpGaD
Flavoxate—CHRM1—Signaling Pathways—CCR5—multiple sclerosis	7.04e-05	0.00014	CbGpPWpGaD
Flavoxate—CHRM2—Signaling Pathways—CCR5—multiple sclerosis	6.94e-05	0.000138	CbGpPWpGaD
Flavoxate—CHRM1—Signaling Pathways—IL2RA—multiple sclerosis	6.93e-05	0.000138	CbGpPWpGaD
Flavoxate—CHRM1—Signaling by GPCR—IL2—multiple sclerosis	6.88e-05	0.000137	CbGpPWpGaD
Flavoxate—CHRM2—Signaling Pathways—IL2RA—multiple sclerosis	6.84e-05	0.000136	CbGpPWpGaD
Flavoxate—CHRM2—Signaling by GPCR—IL2—multiple sclerosis	6.79e-05	0.000135	CbGpPWpGaD
Flavoxate—CHRM1—Signaling Pathways—APOE—multiple sclerosis	6.4e-05	0.000127	CbGpPWpGaD
Flavoxate—CHRM2—Signaling Pathways—APOE—multiple sclerosis	6.32e-05	0.000126	CbGpPWpGaD
Flavoxate—PDE4D—Signaling Pathways—IL6—multiple sclerosis	6.32e-05	0.000126	CbGpPWpGaD
Flavoxate—PDE4A—Signaling Pathways—IL6—multiple sclerosis	6.01e-05	0.00012	CbGpPWpGaD
Flavoxate—CHRM1—Signaling Pathways—CD80—multiple sclerosis	5.79e-05	0.000115	CbGpPWpGaD
Flavoxate—CHRM2—Signaling Pathways—CD80—multiple sclerosis	5.71e-05	0.000114	CbGpPWpGaD
Flavoxate—PDE4B—Signaling Pathways—IL6—multiple sclerosis	5.56e-05	0.000111	CbGpPWpGaD
Flavoxate—CHRM1—Signaling Pathways—POMC—multiple sclerosis	5.5e-05	0.000109	CbGpPWpGaD
Flavoxate—CHRM2—Signaling Pathways—POMC—multiple sclerosis	5.43e-05	0.000108	CbGpPWpGaD
Flavoxate—CHRM1—Signaling Pathways—CCL2—multiple sclerosis	5.38e-05	0.000107	CbGpPWpGaD
Flavoxate—CHRM2—Signaling Pathways—CCL2—multiple sclerosis	5.31e-05	0.000106	CbGpPWpGaD
Flavoxate—CHRM1—Signaling by GPCR—MAPK1—multiple sclerosis	5.26e-05	0.000105	CbGpPWpGaD
Flavoxate—CHRM2—Signaling by GPCR—MAPK1—multiple sclerosis	5.2e-05	0.000103	CbGpPWpGaD
Flavoxate—CHRM1—Signaling Pathways—TYK2—multiple sclerosis	4.89e-05	9.73e-05	CbGpPWpGaD
Flavoxate—CHRM2—Signaling Pathways—TYK2—multiple sclerosis	4.82e-05	9.6e-05	CbGpPWpGaD
Flavoxate—CHRM1—Signaling Pathways—IL2—multiple sclerosis	4.07e-05	8.09e-05	CbGpPWpGaD
Flavoxate—CHRM1—Signaling by GPCR—IL6—multiple sclerosis	4.04e-05	8.05e-05	CbGpPWpGaD
Flavoxate—CHRM2—Signaling Pathways—IL2—multiple sclerosis	4.01e-05	7.99e-05	CbGpPWpGaD
Flavoxate—CHRM2—Signaling by GPCR—IL6—multiple sclerosis	3.99e-05	7.95e-05	CbGpPWpGaD
Flavoxate—CHRM1—Signaling Pathways—MMP9—multiple sclerosis	3.85e-05	7.66e-05	CbGpPWpGaD
Flavoxate—CHRM2—Signaling Pathways—MMP9—multiple sclerosis	3.8e-05	7.56e-05	CbGpPWpGaD
Flavoxate—CHRM1—Signaling Pathways—STAT3—multiple sclerosis	3.42e-05	6.81e-05	CbGpPWpGaD
Flavoxate—CHRM2—Signaling Pathways—STAT3—multiple sclerosis	3.38e-05	6.72e-05	CbGpPWpGaD
Flavoxate—CHRM1—Signaling Pathways—MYC—multiple sclerosis	3.18e-05	6.33e-05	CbGpPWpGaD
Flavoxate—CHRM1—Signaling Pathways—TGFB1—multiple sclerosis	3.17e-05	6.31e-05	CbGpPWpGaD
Flavoxate—CHRM2—Signaling Pathways—MYC—multiple sclerosis	3.14e-05	6.25e-05	CbGpPWpGaD
Flavoxate—CHRM2—Signaling Pathways—TGFB1—multiple sclerosis	3.13e-05	6.23e-05	CbGpPWpGaD
Flavoxate—CHRM1—Signaling Pathways—MAPK1—multiple sclerosis	3.11e-05	6.19e-05	CbGpPWpGaD
Flavoxate—CHRM2—Signaling Pathways—MAPK1—multiple sclerosis	3.07e-05	6.11e-05	CbGpPWpGaD
Flavoxate—CHRM1—Signaling Pathways—IL6—multiple sclerosis	2.39e-05	4.76e-05	CbGpPWpGaD
Flavoxate—CHRM2—Signaling Pathways—IL6—multiple sclerosis	2.36e-05	4.7e-05	CbGpPWpGaD
